Basal Cell Carcinoma
5 drugs221 FAERS reportsMedDRA PT
GET
/api/v1/reaction/basal-cell-carcinomaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Basal Cell Carcinoma (5)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Sulconazole14.5%
- 2Homosalate282.9%
- 3Oxybenzone192.7%
- 4Vismodegib1371.6%
- 5Brexucabtagene Autoleucel36—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Product Expiration Date Issue2 shared · 0.29
- Skin Cancer2 shared · 0.25
- Malignant Melanoma2 shared · 0.22
- Sunburn2 shared · 0.17
- Circumstance Or Information Capable Of Leading To Medication Error2 shared · 0.11
- Application Site Erythema2 shared · 0.05
- Eye Irritation2 shared · 0.03
- Product Use Issue2 shared · 0.01
- Confusional State2 shared · 0.01
- Erythema2 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.